Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Kidney Diseases | 14 | 2018 | 28 | 2.330 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 15 | 2026 | 46 | 2.090 |
Why?
|
| Kidney | 21 | 2016 | 289 | 1.220 |
Why?
|
| Disease Progression | 11 | 2026 | 481 | 0.470 |
Why?
|
| Kidney Failure, Chronic | 4 | 2010 | 70 | 0.400 |
Why?
|
| Radioisotope Renography | 3 | 2016 | 29 | 0.340 |
Why?
|
| Rats | 18 | 2019 | 1594 | 0.310 |
Why?
|
| RNA, Messenger | 9 | 2001 | 668 | 0.280 |
Why?
|
| Verapamil | 1 | 2008 | 9 | 0.280 |
Why?
|
| Nephrology | 1 | 2008 | 5 | 0.280 |
Why?
|
| Renal Dialysis | 2 | 2007 | 53 | 0.280 |
Why?
|
| Animals | 26 | 2019 | 10756 | 0.270 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 41 | 0.270 |
Why?
|
| Cell Proliferation | 2 | 2008 | 827 | 0.270 |
Why?
|
| Epidermal Growth Factor | 3 | 2003 | 24 | 0.240 |
Why?
|
| Molecular Chaperones | 2 | 1995 | 50 | 0.230 |
Why?
|
| Chemokine CCL2 | 2 | 2003 | 47 | 0.230 |
Why?
|
| Hippurates | 2 | 2015 | 25 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 1 | 2026 | 249 | 0.220 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 101 | 0.210 |
Why?
|
| Cyclic AMP | 4 | 2008 | 96 | 0.190 |
Why?
|
| TRPP Cation Channels | 2 | 2017 | 36 | 0.190 |
Why?
|
| Rats, Inbred Strains | 8 | 2001 | 64 | 0.180 |
Why?
|
| Sialoglycoproteins | 1 | 2001 | 8 | 0.180 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 221 | 0.180 |
Why?
|
| Humans | 16 | 2026 | 29078 | 0.170 |
Why?
|
| Calcium Oxalate | 1 | 2019 | 1 | 0.150 |
Why?
|
| Kidney Tubules | 1 | 2019 | 22 | 0.150 |
Why?
|
| Heterozygote | 6 | 2015 | 69 | 0.140 |
Why?
|
| Europe | 1 | 2018 | 100 | 0.140 |
Why?
|
| Glycoproteins | 2 | 1995 | 124 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2016 | 554 | 0.130 |
Why?
|
| Gene Expression | 2 | 1995 | 417 | 0.120 |
Why?
|
| Testosterone | 1 | 1997 | 74 | 0.120 |
Why?
|
| Iodohippuric Acid | 1 | 2016 | 9 | 0.120 |
Why?
|
| Male | 18 | 2019 | 14049 | 0.120 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1995 | 24 | 0.120 |
Why?
|
| Fluorine Radioisotopes | 1 | 2015 | 26 | 0.120 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 1995 | 1 | 0.120 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1995 | 45 | 0.110 |
Why?
|
| Female | 17 | 2019 | 15740 | 0.110 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2014 | 9 | 0.110 |
Why?
|
| Glycine | 1 | 2014 | 33 | 0.110 |
Why?
|
| Coordination Complexes | 1 | 2014 | 28 | 0.110 |
Why?
|
| Urothelium | 1 | 2014 | 35 | 0.110 |
Why?
|
| CD13 Antigens | 1 | 2014 | 26 | 0.110 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 75 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 37 | 0.100 |
Why?
|
| Technetium | 1 | 2014 | 43 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2014 | 97 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2014 | 465 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 88 | 0.100 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 166 | 0.090 |
Why?
|
| Disease Models, Animal | 8 | 2015 | 1522 | 0.090 |
Why?
|
| Renal Insufficiency | 2 | 2004 | 20 | 0.080 |
Why?
|
| Body Fluids | 2 | 2008 | 18 | 0.080 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 1990 | 2 | 0.080 |
Why?
|
| Kidney Medulla | 1 | 1990 | 2 | 0.080 |
Why?
|
| Sorbitol | 1 | 1990 | 3 | 0.080 |
Why?
|
| Piperacillin | 1 | 2010 | 2 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 1 | 1990 | 6 | 0.080 |
Why?
|
| Aldehyde Reductase | 1 | 1990 | 7 | 0.080 |
Why?
|
| Mice | 10 | 2019 | 4845 | 0.080 |
Why?
|
| Drug Hypersensitivity | 1 | 2010 | 23 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2008 | 95 | 0.080 |
Why?
|
| Blood Urea Nitrogen | 4 | 1997 | 13 | 0.070 |
Why?
|
| Ammonium Chloride | 2 | 2001 | 4 | 0.070 |
Why?
|
| Homozygote | 4 | 1997 | 36 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 113 | 0.070 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2008 | 1 | 0.070 |
Why?
|
| Receptors, Vasopressin | 1 | 2008 | 2 | 0.070 |
Why?
|
| Hormone Antagonists | 1 | 2008 | 6 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 34 | 0.070 |
Why?
|
| Contraindications | 1 | 2008 | 13 | 0.070 |
Why?
|
| Caspases | 1 | 2008 | 43 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 1987 | 15 | 0.070 |
Why?
|
| Polyomavirus Infections | 1 | 2007 | 7 | 0.070 |
Why?
|
| Sirolimus | 1 | 2008 | 76 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2007 | 34 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2007 | 43 | 0.060 |
Why?
|
| Calcium | 1 | 2008 | 243 | 0.060 |
Why?
|
| Reference Values | 2 | 2001 | 200 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2003 | 6 | 0.060 |
Why?
|
| Sodium Chloride | 2 | 1996 | 68 | 0.060 |
Why?
|
| Clusterin | 2 | 1995 | 6 | 0.060 |
Why?
|
| Disease Management | 1 | 2026 | 91 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2016 | 137 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 538 | 0.060 |
Why?
|
| Research | 1 | 2005 | 93 | 0.060 |
Why?
|
| Hypertension | 1 | 2008 | 309 | 0.060 |
Why?
|
| Apoptosis | 1 | 2008 | 781 | 0.050 |
Why?
|
| Organ Size | 4 | 2001 | 88 | 0.050 |
Why?
|
| Diabetes Insipidus | 2 | 1995 | 2 | 0.050 |
Why?
|
| Dehydration | 2 | 1995 | 7 | 0.050 |
Why?
|
| Diuretics | 2 | 1995 | 13 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2007 | 19 | 0.050 |
Why?
|
| Uremia | 4 | 2001 | 5 | 0.050 |
Why?
|
| Osteopontin | 1 | 2001 | 10 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2003 | 1022 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2008 | 2430 | 0.040 |
Why?
|
| Cytokines | 1 | 2003 | 456 | 0.040 |
Why?
|
| Sodium Bicarbonate | 1 | 2001 | 6 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2001 | 175 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2001 | 73 | 0.040 |
Why?
|
| United States | 1 | 2026 | 2252 | 0.040 |
Why?
|
| Citric Acid | 1 | 2019 | 5 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2019 | 11 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 74 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1998 | 15 | 0.040 |
Why?
|
| Macrophages | 1 | 2001 | 306 | 0.040 |
Why?
|
| Risk Factors | 1 | 2004 | 2138 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2000 | 482 | 0.030 |
Why?
|
| Biomarkers | 2 | 2003 | 787 | 0.030 |
Why?
|
| Renal Agents | 1 | 1997 | 2 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 1997 | 9 | 0.030 |
Why?
|
| Orchiectomy | 1 | 1997 | 12 | 0.030 |
Why?
|
| Rats, Mutant Strains | 2 | 1996 | 16 | 0.030 |
Why?
|
| Genes, myc | 2 | 1996 | 9 | 0.030 |
Why?
|
| Ovariectomy | 1 | 1997 | 53 | 0.030 |
Why?
|
| Potassium | 1 | 1996 | 43 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 514 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 1996 | 35 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1996 | 7 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1995 | 12 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 1995 | 11 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 46 | 0.030 |
Why?
|
| Adenoviridae | 1 | 1996 | 68 | 0.030 |
Why?
|
| Paclitaxel | 1 | 1997 | 201 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 79 | 0.030 |
Why?
|
| Lovastatin | 1 | 1995 | 6 | 0.030 |
Why?
|
| Epithelial Cells | 3 | 2003 | 267 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1996 | 74 | 0.030 |
Why?
|
| Culture Media | 1 | 1995 | 99 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 490 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1995 | 15 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 1997 | 1672 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1998 | 524 | 0.030 |
Why?
|
| RNA | 1 | 1995 | 111 | 0.030 |
Why?
|
| Dogs | 1 | 1995 | 510 | 0.030 |
Why?
|
| Acetates | 1 | 2014 | 45 | 0.030 |
Why?
|
| Down-Regulation | 1 | 1995 | 202 | 0.030 |
Why?
|
| Base Sequence | 1 | 1995 | 589 | 0.030 |
Why?
|
| Radioisotopes | 1 | 2014 | 11 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2014 | 22 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 130 | 0.030 |
Why?
|
| Alanine | 1 | 2014 | 40 | 0.030 |
Why?
|
| Up-Regulation | 1 | 1995 | 247 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 1057 | 0.030 |
Why?
|
| Kidney Cortex | 2 | 2003 | 5 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 333 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 461 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2003 | 33 | 0.020 |
Why?
|
| Age Factors | 2 | 2000 | 740 | 0.020 |
Why?
|
| Middle Aged | 4 | 2007 | 7458 | 0.020 |
Why?
|
| Peptides | 1 | 2014 | 297 | 0.020 |
Why?
|
| Histones | 2 | 1988 | 96 | 0.020 |
Why?
|
| Bacteremia | 1 | 2010 | 81 | 0.020 |
Why?
|
| Adult | 3 | 2010 | 8080 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 1987 | 21 | 0.020 |
Why?
|
| Fibrosis | 2 | 2001 | 143 | 0.020 |
Why?
|
| Autopsy | 1 | 2007 | 26 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 20 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 69 | 0.020 |
Why?
|
| Regeneration | 1 | 1987 | 77 | 0.020 |
Why?
|
| Mice, Inbred DBA | 2 | 1996 | 30 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 468 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1987 | 645 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1998 | 183 | 0.010 |
Why?
|
| Cyst Fluid | 1 | 2003 | 2 | 0.010 |
Why?
|
| Chemokine CCL7 | 1 | 2003 | 3 | 0.010 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2003 | 45 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2003 | 2 | 0.010 |
Why?
|
| Sex Factors | 2 | 1995 | 473 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2003 | 6 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 79 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 36 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 124 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 267 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2007 | 639 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 251 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 515 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 585 | 0.010 |
Why?
|
| Bicarbonates | 1 | 2001 | 3 | 0.010 |
Why?
|
| Chlorides | 1 | 2000 | 13 | 0.010 |
Why?
|
| Ammonia | 1 | 2001 | 18 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 62 | 0.010 |
Why?
|
| Species Specificity | 1 | 2001 | 196 | 0.010 |
Why?
|
| Aging | 2 | 1998 | 1029 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 485 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 42 | 0.010 |
Why?
|
| COS Cells | 1 | 1998 | 49 | 0.010 |
Why?
|
| Epithelium | 1 | 1998 | 40 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 815 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1998 | 79 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1998 | 103 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1997 | 58 | 0.010 |
Why?
|
| Random Allocation | 1 | 1997 | 152 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 336 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 1619 | 0.010 |
Why?
|
| Papaverine | 1 | 1996 | 1 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 24 | 0.010 |
Why?
|
| Dopamine | 1 | 1996 | 24 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 1996 | 34 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1996 | 36 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1996 | 58 | 0.010 |
Why?
|
| Inflammation | 1 | 2001 | 669 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1996 | 87 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1996 | 35 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 79 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1996 | 44 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1996 | 118 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1996 | 212 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 612 | 0.010 |
Why?
|
| Nephritis | 1 | 1995 | 10 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1995 | 393 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 405 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 5627 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1988 | 3 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 94 | 0.000 |
Why?
|
| Cell Division | 1 | 1988 | 154 | 0.000 |
Why?
|
| Body Weight | 1 | 1988 | 253 | 0.000 |
Why?
|